EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells

Thanaporn Kulthawatsiri, Yingpinyapat Kittirat, Jutarop Phetcharaburanin, Jittima Tomacha, Bundit Promraksa, Arporn Wangwiwatsin iD, Poramate Klanrit, Attapol Titapun, Watcharin Loilome, Nisana Namwat iD

PeerJ · 2023

DOI: 10.7717/peerj.16512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Thanaporn Kulthawatsiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Opisthorchiasis, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khon Kaen University, Cholangiocarcinoma Research Institute to Nisana Namwat.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Niclosamide is an oral anthelminthic drug that has been used for treating tapeworm infections. Its mechanism involves the disturbance of mitochondrial membrane potential that in turn inhibits oxidative phosphorylation leading to ATP depletion. To date, niclosamide has been validated as the potent anti-cancer agent against several cancers. However, the molecular mechanisms underlying the effects of niclosamide on the liver fluke Opisthorchis viverrini (Ov)-associated cholangiocarcinoma (CCA) cell functions remain to be elucidated. The aims of this study were to investigate the effects of niclosamide on CCA cell proliferation and on metabolic phenoconversion through the alteration of metabolites associated with mitochondrial function in CCA cell lines. Materials and Methods The inhibitory effect of niclosamide on CCA cells was determined using SRB assay. A mitochondrial membrane potential using tetramethylrhodamine, ethyl ester-mitochondrial membrane potential (TMRE-MMP) assay was conducted. Liquid chromatography-mass spectrometry-based metabolomics was employed to investigate the global metabolic changes upon niclosamide treatment. ATP levels were measured using CellTiter-Glo ® luminescent cell viability assay. NAD metabolism was examined by the NAD + /NADH ratio.

Results

Niclosamide strongly inhibited CCA cell growth and reduced the MMP of CCA cells. An orthogonal partial-least square regression analysis revealed that the effects of niclosamide on suppressing cell viability and MMP of CCA cells were significantly associated with an increase in niacinamide, a precursor in NAD synthesis that may disrupt the electron transport system leading to suppression of NAD + /NADH ratio and ATP depletion.

Conclusion

Our findings unravel the mode of action of niclosamide in the energy depletion that could potentially serve as the promising therapeutic strategy for CCA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OpisthorchiasisCholangiocarcinomaBile Duct NeoplasmsAnimalsNiclosamideNADMembrane Potential, MitochondrialBile Ducts, IntrahepaticAdenosine Triphosphate

Stichwörter der Autor:innen

CholangiocarcinomaLC-MSMetabolomicsNiclosamide

Substanzen

NiclosamideNADAdenosine Triphosphate

Autor:innen und Institutionen

  • Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Khon Kaen, Thailand.
  • Khon Kaen University Phenome Centre, Khon Kaen University, Khon Kaen, Khon Kaen, Thailand.
  • Department of Medical Sciences/Regional Medical Sciences Center 2, Ministry of Public Health, Phitsanulok, Phitsanulok, Thailand.
  • Department of Systems Biosciences and Computational Medicine/Faculty of Medicine, Khon Kaen University, Khon Kaen, Khon Kaen, Thailand.
  • Department of Surgery/Faculty of Medicine, Khon Kaen University, Khon Kaen, Khon Kaen, Thailand.

ORCID-Profile: Arporn Wangwiwatsin, Nisana Namwat

Förderung

  • Khon Kaen University
  • Cholangiocarcinoma Research Institute to Nisana Namwat

Zitieren

APA

Kulthawatsiri, T., Kittirat, Y., Phetcharaburanin, J., Tomacha, J., Promraksa, B., Wangwiwatsin, A., Klanrit, P., Titapun, A., Loilome, W., & Namwat, N. (2023). Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. PeerJ. https://doi.org/10.7717/peerj.16512

Vancouver

Kulthawatsiri T, Kittirat Y, Phetcharaburanin J, Tomacha J, Promraksa B, Wangwiwatsin A, et al. Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. PeerJ. 2023. doi:10.7717/peerj.16512

BibTeX
@article{Kulthawatsiri2023,
  author = {Kulthawatsiri, Thanaporn and Kittirat, Yingpinyapat and Phetcharaburanin, Jutarop and Tomacha, Jittima and Promraksa, Bundit and Wangwiwatsin, Arporn and Klanrit, Poramate and Titapun, Attapol and Loilome, Watcharin and Namwat, Nisana},
  title = {Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.16512}
}
Kostenlos starten →